CybeRelease: (OTC: CCRC) Finalizes Acquisition of Clinicares

(CybeRelease, April 16, 2007) - Lake Harmony, PA - Vision Digital Multimedia Corporation announced that it has completed the acquisition of Clinicares Co. Ltd. and has changed its name to Clinicares, Inc. (OTC PK: CCRC). The stock trading symbol is CCRC.

Through the acquisition of Clinicares Co. Ltd., VDGM is a Biotech Development Stage Company involved in R&D, Manufacturing, Distribution and Marketing of its proprietary products in the anti-aging, cosmeceutical, and beauty aid fields with both branded and private label activities.

The company’s primary focus and product line is Clinicares Treatment Solutions, or “CTS” which includes the clinically proven peptide-based products and Microneedle-Roller consumer product, called Clinicares Roller. The perfect combination of these product lines is aimed at replacing dermabrasion, chemical and laser resurfacing as a new drug delivery system with the microneedle-roller for clinical and consumer use.

CTS is marketed directly to physicians and to consumers via direct marketing globally. It has already enjoyed success on home shopping networks globally and is recognized by numerous cosmetic surgeons as a breakthrough in the industry.

“We are excited about moving forward as a public company and expect to file all requisite reports to become fully reporting in the first quarter of this year,” said Clinicares President Halen Bach.

About the Clinicares Roller and Peptide Product line:

With the conventional application of creams, gels or lotions only a fraction, like less than 0.5%, of their active substances can penetrate the epidermal barrier; 99.5% are lost. The upper skin layer, epidermis, consists of several layers, and their structure is like a brick wall. The Clinicares Roller, studded with nearly 200 extremely fine needles of medical grade stainless steel with a tip length of 0.2mm, is the latest revolutionary cosmeceutical tool incorporated in skin care treatments. When applied to the surface of the skin, it creates deep micro channels in the layer of dead cells that normally protects the skin. These enable the active ingredients of peptide-based products to penetrate more deeply and in greater quantities than simply applying the preparation to the surface.

To read the complete release, go to http://biz.yahoo.com/iw/070416/0238809.html

For a Free Newsletter, go to http://www.OTCReporter.com

CybeRelease Gainers are SunPower Corporation (Nasdaq: SPWR), Cutera, Inc. (Nasdaq: CUTR), Focus Media Holding Limited (Nasdaq: FMCN), Rural Cellular Corporation (Nasdaq: RCCC), Crocs, Inc. (Nasdaq: CROX), Methanex Corporation (Nasdaq: MEOH), Sigma Designs, Inc. (Nasdaq: SIGM) and Baidu.com, Inc. (Nasdaq: BIDU).

CybeRelease Decliners are SuperGen, Inc. (Nasdaq: SUPG), Dress Barn, Inc. (The) (Nasdaq: DBRN), Neurochem Inc. (Nasdaq: NRMX), CEPHEID (Nasdaq: CPHD), Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN), Parlux Fragrances, Inc. (Nasdaq: PARL), Children’s Place Retail Stores, Inc. (The) (Nasdaq: PLCE) and TeleTech Holdings, Inc. (Nasdaq: TTEC).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail